glp-1 medications in weight management for Loss: How to Get Started | News GLP-1 Medications vs. Traditional Weight

Recognizing the significant weight loss potential of semaglutide, the FDA later approved Wegovy (semaglutide) specifically for chronic weight management in adults with obesity (BMI 30 kg/m) or who are overweight (BMI 27 kg/m) and have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol

doi:10.1007/s13105-023-00984-y 213

This interaction activates phospholipase C, promotes inositol triphosphate formation, and induces the release of calcium from intracellular stores, contributing to growth hormone secretory processes

Houston et al., 2013

Wear lightweight clothing and stay cool to reduce excessive sweating and fluid loss

Researchers found no modification to the relationship based on BMI and asthma severity